Clinical Trial Update: Obinutuzumab in Adult Rituximab-Dependent Nephrotic Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of obinutuzumab for adult rituximab-dependent idiopathic nephrotic syndrome is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Nephrotic Syndrome

Drugs mentioned

• Obinutuzumab (obinutuzumab)

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Nephrotic Syndrome，Idiopathic | Phase 2 | Status: NOT_YET_RECRUITING